Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Amebiasis
MeSH D000562 - amebiasis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D011528:
Protozoan infections
170 Companies
44 Drugs
$
Success rate
D000562:
Amebiasis
58 Companies
7 Drugs
$
Success rate
D004404:
Amebic dysentery
0 Companies
0 Drugs
Success rate
D004749:
Entamoebiasis
0 Companies
0 Drugs
Success rate
D008101:
Amebic liver abscess
0 Companies
0 Drugs
Success rate
D015823:
Acanthamoeba keratitis
21 Companies
2 Drugs
$
Success rate
D016776:
Blastocystis infections
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/1
Phase 2
0
%
0/0
Phase 3
83
%
5/6
Approved:
5
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Metronidazole
Taro Pharmaceutical
Metronidazole
Johnson & Johnson
Metronidazole
Sanofi
Chloroquine
Pfizer
Metronidazole
,
Paromomycin
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use